High-Dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors.
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin; Docetaxel; Etoposide; Filgrastim; Gemcitabine; Ifosfamide; Melphalan; Mesna
- Indications Germ cell and embryonal neoplasms
- Focus Therapeutic Use
- 06 Jun 2017 Results (n=69) presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 17 Jun 2016 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.
- 17 Feb 2015 Planned primary completion date changed from 1 Jun 2016 to 1 Jun 2017 as reported by ClinicalTrials.gov.